87 related articles for article (PubMed ID: 492047)
1. [The effect of pentoxifylline on liver perfusion: a comparative study in patients with liver diseases and in normal subjects, using 198Au-colloid-scintigraphy (author's transl)].
Koppenhagen K; Wenig HG
Med Klin; 1979 Aug; 74(35):1254-6. PubMed ID: 492047
[TBL] [Abstract][Full Text] [Related]
2. Cerebral blood flow under hypobaric conditions: effects of pentoxifylline ('Trental' 400).
Koppenhagen K
Pharmatherapeutica; 1984; 4(1):1-5. PubMed ID: 6504944
[TBL] [Abstract][Full Text] [Related]
3. [Clinical trial of Trental 100 in patients with peripheral arterial occlusive diseases (author's transl)].
von Westphalen JG
MMW Munch Med Wochenschr; 1977 Jul; 119(26):901-4. PubMed ID: 408616
[TBL] [Abstract][Full Text] [Related]
4. [Functional state of the cardiovascular system in chronic diffuse liver diseases].
Bronovets IN
Ter Arkh; 1979; 51(8):89-92. PubMed ID: 505313
[No Abstract] [Full Text] [Related]
5. [Changes in central hemodynamics in chronic liver diseases (radiocardiologic study)].
Loginov AS; Khodarev NN; Astaf'eva OV; Sakharova GN
Med Radiol (Mosk); 1987 Apr; 32(4):26-30. PubMed ID: 3586907
[TBL] [Abstract][Full Text] [Related]
6. A controlled trial of pentoxifylline (Trental 400) in intermittent claudication: clinical, haemostatic and rheological effects.
Reilly DT; Quinton DN; Barrie WW
N Z Med J; 1987 Jul; 100(828):445-7. PubMed ID: 3330188
[TBL] [Abstract][Full Text] [Related]
7. [Significane of a radiometric method of study of the cardio-portal blood circulation in patients with chronic liver diseases].
Bondar' ZA; Novikova TF
Klin Med (Mosk); 1967 Mar; 45(3):26-32. PubMed ID: 5604366
[No Abstract] [Full Text] [Related]
8. Pentoxifylline (Trental) has no significant effect on laboratory parameters in sickle cell disease.
Billett HH; Kaul DK; Connel MM; Fabry ME; Nagel RL
Nouv Rev Fr Hematol (1978); 1989; 31(6):403-7. PubMed ID: 2694097
[TBL] [Abstract][Full Text] [Related]
9. [Effects of pentoxifylline on diastolic heart function in patients with angina pectoris and an increased left ventricular wall mass].
Heublein B; Franz N; Modersohn D; Linss G; Lange T; Specht FK; Heublein-Balint EG
Herz; 1988 Apr; 13(2):124-35. PubMed ID: 2967793
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of chronic arterial occlusive disease. Clinical study with a new galenic preparation of Pentoxifyllin (Trental 400) (author's transl)].
Angelkort B; Doppelfeld E
Med Klin; 1978 May; 73(21):791-7. PubMed ID: 651768
[TBL] [Abstract][Full Text] [Related]
11. Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.
Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
J Med; 1988; 19(2):89-107. PubMed ID: 3049876
[TBL] [Abstract][Full Text] [Related]
12. [Assessment of the therapeutic effect of Trental 400. Double-blind study in geriatric patients with circulatory disorders].
Feine-Haake G
Fortschr Med; 1977 Jan; 95(1):48-51. PubMed ID: 401759
[TBL] [Abstract][Full Text] [Related]
13. On the assessment of the efficacy of pentoxifylline (Trental).
Rössner M; Müller R
J Med; 1987; 18(1):1-15. PubMed ID: 3298515
[TBL] [Abstract][Full Text] [Related]
14. Measurement of cerebral blood flow following intravenous administration of pentoxifyline ('Trentral').
Koppenhagen K; Wenig HG; Müller K
Curr Med Res Opin; 1977; 4(7):521-8. PubMed ID: 844329
[TBL] [Abstract][Full Text] [Related]
15. Effect of pentoxifylline on regional cerebral blood flow in patients with cerebrovascular disease.
Hartmann A
Pharmatherapeutica; 1981; 2(8):528-31. PubMed ID: 7255509
[TBL] [Abstract][Full Text] [Related]
16. Endogenous bile acid tolerance test and its clinical significance--series of total bile acid levels in plasma before and after contraction of the gallbladder in patients with chronic liver diseases.
Iwamura K
Tokai J Exp Clin Med; 1980 Jan; 5(1):113-29. PubMed ID: 7385259
[TBL] [Abstract][Full Text] [Related]
17. [Blood rheology in chronic arterial occlusive disease as influenced by vasodilators (author's transl)].
Störmer B; Kleinschmidt F; Loose D; Kremer K
Dtsch Med Wochenschr; 1978 Apr; 103(16):694-8. PubMed ID: 639718
[TBL] [Abstract][Full Text] [Related]
18. Caffeine clearance by two point analysis: a measure of liver function in chronic liver disease.
Wittayalertpanya S; Israsena S; Thamaree S; Tongnopnoua P; Komolmit P
Tokai J Exp Clin Med; 1996 Dec; 21(4-6):195-201. PubMed ID: 9300980
[TBL] [Abstract][Full Text] [Related]
19. [Use of trental in combined treatment of viral hepatitis].
Vasil'ev VS; Pron'ko NV
Klin Med (Mosk); 1990 Mar; 68(3):68-70. PubMed ID: 2370759
[TBL] [Abstract][Full Text] [Related]
20. Comparative pharmacokinetic analysis of novel sustained-release dosage forms of pentoxifylline in healthy subjects.
Raz I; Ben-David J; Hussein Z; Samara E
Int J Clin Pharmacol Ther Toxicol; 1988 Apr; 26(4):206-8. PubMed ID: 3403100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
